Compare Haedal Protocol (HAEDAL) vs Mira (MIRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Haedal Protocol vs Mira — how do they compare? Haedal Protocol trades at Rp295.73 (market cap Rp141,54M, Rp30,88M 24h volume), while Mira trades at Rp700.02 (market cap Rp226,43M, Rp101,47M 24h volume). The key difference: Mira is the larger of the two by market cap, and Haedal Protocol's circulating supply is 483,3M / 1B HAEDAL (49%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold Haedal Protocol for 15 Days and Mira for 22 Days on average.
| HAEDAL | MIRA | |
|---|---|---|
Market Cap | Rp141,54M | Rp226,43M |
Volume (24h) | Rp30,88M | Rp101,47M |
Circulating Supply | 483,3M / 1B HAEDAL (49%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 15 Days | 22 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Haedal Protocol currently trades at Rp288.18 with a market cap of Rp139.43M, showing bearish technical signals from moving averages while oscillators remain neutral. The token has 49% circulating supply with an average hold time of 15 days. Current price sits near the pivot point of Rp288, with immediate support at Rp283 and resistance at Rp292. No major protocol updates or ecosystem developments were identified in recent analysis.
Overall outlook remains cautious with bearish technical momentum outweighing neutral oscillators. Key opportunity lies in potential bounce from support levels, while major risks include low liquidity and limited market depth. Investors should monitor for any protocol developments that could drive adoption.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Haedal Protocol
Haedal is a leading liquid staking protocol built specifically on the Sui blockchain. It provides a reliable infrastructure that enables users to stake their SUI and Walrus tokens with validators, allowing them to earn ongoing consensus rewards. Additionally, users can unlock liquidity in the form of liquid staking tokens (LST), which can be utilized across decentralized finance (DeFi) applications. Haedal's goal is to become the primary platform for staking and earning within the Sui ecosystem.
Read more on HAEDAL →About Mira
Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →
